Naba Alsaha Medical Services Co. vs Dr. Sulaiman Al Habib Medical S
A head-to-head of Naba Alsaha Medical Services Co. (9546) and Dr. Sulaiman Al Habib Medical S (4013) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Naba Alsaha Medical Services Co.
9546
21.38 SAR
0.00%
VS
Dr. Sulaiman Al Habib Medical S
4013
215.10 SAR
+1.27%
| Metric | 9546 | 4013 |
|---|---|---|
| Market Cap | 462.00M SAR | 75.29B SAR |
| P/E (TTM) | 8.16 | 31.36 |
| Forward P/E | — | 28.64 |
| P/S | 2.29 | 5.45 |
| P/B | 2.02 | 9.47 |
| EV/EBITDA | 13.43 | 26.07 |
| Dividend Yield | 70.00% | 1.85% |
| Profit Margin | 13.64% | 16.79% |
| Gross Margin | 32.80% | 30.69% |
| Operating Margin | 15.26% | 19.26% |
| Revenue Growth (YoY) | +5.80% | +8.80% |
| FCF Yield | — | 0.81% |
| Debt / Equity | 54.27 | 113.79 |
| Current Ratio | 6.26 | 1.14 |
Which is better: Naba Alsaha Medical Services Co. or Dr. Sulaiman Al Habib Medical S?
- ✓Larger by market cap: Dr. Sulaiman Al Habib Medical S
- ✓Cheaper valuation (lower P/E): Naba Alsaha Medical Services Co.
- ✓Higher dividend yield: Naba Alsaha Medical Services Co.
- ✓More profitable (net margin): Dr. Sulaiman Al Habib Medical S
- ✓Faster revenue growth: Dr. Sulaiman Al Habib Medical S
Across 11 available metrics, Naba Alsaha Medical Services Co. leads 8–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Naba Alsaha Medical Services Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.